These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15019602)

  • 21. Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart.
    Vague P; Selam JL; Skeie S; De Leeuw I; Elte JW; Haahr H; Kristensen A; Draeger E
    Diabetes Care; 2003 Mar; 26(3):590-6. PubMed ID: 12610006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asymptomatic hypoglycaemia: identification and impact.
    Gomis R; Esmatjes E
    Diabetes Metab Res Rev; 2004; 20 Suppl 2():S47-9. PubMed ID: 15551298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
    Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
    Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
    Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
    Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin therapy in children and adolescents with type 1 diabetes.
    Malik FS; Taplin CE
    Paediatr Drugs; 2014 Apr; 16(2):141-50. PubMed ID: 24458650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Insulin therapy of Type I diabetes].
    Berger W
    Ther Umsch; 1996 Dec; 53(12):902-13. PubMed ID: 9036568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of short-term glucose control on glycemic thresholds for epinephrine and hypoglycemic symptoms.
    Burge MR; Sobhy TA; Qualls CR; Schade DS
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5471-8. PubMed ID: 11701724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safe and effective use of a glycemic control protocol for neonates in a cardiac ICU.
    Hebson CL; Chanani NK; Rigby MR; Wolf MJ; Deshpande SR; Montegna LM; Maher KO
    Pediatr Crit Care Med; 2013 Mar; 14(3):284-9. PubMed ID: 23392366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifactorial origin of hypoglycemic symptom unawareness in IDDM. Association with defective glucose counterregulation and better glycemic control.
    Clarke WL; Gonder-Frederick LA; Richards FE; Cryer PE
    Diabetes; 1991 Jun; 40(6):680-5. PubMed ID: 2040384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative efficacy of preprandial or postprandial Humalog Mix75/25 versus glyburide in patients 60 to 80 years of age with type 2 diabetes mellitus.
    Herz M; Sun B; Milicevic Z; Erickson P; Fövènyi J; Grzywa M; Pelikanova T
    Clin Ther; 2002 Jan; 24(1):73-86. PubMed ID: 11833837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of intensive therapy and antecedent hypoglycemia on counterregulatory responses to hypoglycemia in type 2 diabetes.
    Davis SN; Mann S; Briscoe VJ; Ertl AC; Tate DB
    Diabetes; 2009 Mar; 58(3):701-9. PubMed ID: 19073776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Factors for Nocturnal Hypoglycemia in Insulin-treated Patients With Type 2 Diabetes: A Secondary Analysis of Observational Data Derived From an Integrated Clinical Trial Database.
    Bae JP; Duan R; Fu H; Hoogwerf BJ
    Clin Ther; 2017 Sep; 39(9):1790-1798.e7. PubMed ID: 28781218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
    Šoupal J; Petruželková L; Grunberger G; Hásková A; Flekač M; Matoulek M; Mikeš O; Pelcl T; Škrha J; Horová E; Škrha J; Parkin CG; Svačina Š; Prázný M
    Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.
    Heine RJ; Van Gaal LF; Johns D; Mihm MJ; Widel MH; Brodows RG;
    Ann Intern Med; 2005 Oct; 143(8):559-69. PubMed ID: 16230722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. INPATIENT HYPOGLYCEMIC EVENTS IN A COMPARATIVE EFFECTIVENESS TRIAL FOR GLYCEMIC CONTROL IN A HIGH-RISK POPULATION.
    Welsh N; Derby T; Gupta S; Fulkerson C; Oakes DJ; Schmidt K; Parikh ND; Norvell JP; Levitsky J; Rademaker A; Molitch ME; Wallia A
    Endocr Pract; 2016 Sep; 22(9):1040-7. PubMed ID: 27124695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs.
    Rossetti P; Porcellati F; Bolli GB; Fanelli CG
    Diabetes Care; 2008 Feb; 31 Suppl 2():S113-20. PubMed ID: 18227470
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypoglycemia and the hypoglycemic unawareness syndrome.
    Hirsch IB
    Diabetes Technol Ther; 2000; 2 Suppl 1():S81-7. PubMed ID: 11469638
    [No Abstract]   [Full Text] [Related]  

  • 38. EADSG Guidelines: Insulin Therapy in Diabetes.
    Silver B; Ramaiya K; Andrew SB; Fredrick O; Bajaj S; Kalra S; Charlotte BM; Claudine K; Makhoba A
    Diabetes Ther; 2018 Apr; 9(2):449-492. PubMed ID: 29508275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin therapy in type 2 diabetes.
    Mudaliar S; Edelman SV
    Endocrinol Metab Clin North Am; 2001 Dec; 30(4):935-82. PubMed ID: 11727406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trial.
    Heller S; Koenen C; Bode B
    Clin Ther; 2009 Oct; 31(10):2086-97. PubMed ID: 19922879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.